GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (CHIX:DIMp) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Sartorius Stedim Biotech (CHIX:DIMP) Future 3-5Y EPS without NRI Growth Rate : 44.32 (As of Jul. 15, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Sartorius Stedim Biotech Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate is 44.32.

Competitive Comparison of Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Sartorius Stedim Biotech  (CHIX:DIMp) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Sartorius Stedim Biotech Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (CHIX:DIMp) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XPAR:AMPLI XPAR:ALCJ XPAR:MLBON XPAR:ALSPW XPAR:ALSAF ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XTER:SRT WST BAX HOLX COO ALGN
Traded in Other Exchanges
SRTOY:USA SDMHF:USA 0RG8:UK DIM:France 56S1:Germany DIM:Austria
Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Website
https://www.sartorius.com
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.

Sartorius Stedim Biotech Headlines

No Headlines